Nicholas Britt
Overview
Explore the profile of Nicholas Britt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McGarry J, Mintmier B, Metzger M, Giri N, Britt N, Basu P, et al.
J Biol Inorg Chem
. 2024 Dec;
29(7-8):811-819.
PMID: 39633165
Nitrate reductases play pivotal roles in nitrogen metabolism by leveraging the molybdopterin cofactor to facilitate the reduction of nitrate to nitrite. Periplasmic nitrate reductases (NapA) utilize nitrate as a terminal...
2.
Haberberger J, Pegram W, Britt N, Schiavone K, Severson E, Sharaf R, et al.
Oncologist
. 2023 Aug;
29(1):e47-e58.
PMID: 37619245
The authors present a cohort of 661 young adult glioblastomas diagnosed using 2016 WHO World Health Organization Classification of Tumors of the Central Nervous System, utilizing comprehensive genomic profiling (CGP)...
3.
Dorsey J, Mott R, Lack C, Britt N, Ramkissoon S, Morris B, et al.
Oncol Lett
. 2022 Aug;
24(3):326.
PMID: 35949590
Gorlin syndrome or nevoid basal cell carcinoma syndrome is a rare genetic disease characterized by predisposition to congenital defects, basal cell carcinomas and medulloblastoma. The syndrome results from a heritable...
4.
Huang R, Gottberg-Williams A, Vang P, Yang S, Britt N, Kaur J, et al.
JTO Clin Res Rep
. 2021 Sep;
2(2):100100.
PMID: 34589979
Introduction: In this study, we sought to further characterize ROS1 protein expression in solid tumors with the complete spectrum of genomic alterations. Methods: ROS1 immunohistochemistry (IHC) was performed using the...
5.
Badowski M, Britt N, Huesgen E, Lewis M, Miller M, Nowak K, et al.
Pharmacotherapy
. 2021 Jan;
41(3):299-314.
PMID: 33404067
Pharmacotherapy considerations are often a concern for transgender individuals who are living with human immunodeficiency virus (HIV) due to concerns for drug-drug interactions between their hormone and antiretroviral therapies. Many...
6.
Krauchunas A, Werner M, Britt N, Chen D, Maddox A, Singson A
MicroPubl Biol
. 2020 Oct;
2020.
PMID: 33029584
No abstract available.
7.
Rankin A, Johnson A, Roos A, Kannan G, Knipstein J, Britt N, et al.
Oncologist
. 2020 Sep;
26(1):e153-e163.
PMID: 32918774
RAF family protein kinases signal through the MAPK pathway to orchestrate cellular proliferation, survival, and transformation. Identifying BRAF alterations in pediatric cancers is critically important as therapeutic agents targeting BRAF...
8.
Valiakhmetova A, Gorelyshev S, Konovalov A, Trunin Y, Savateev A, Kram D, et al.
Oncologist
. 2020 Feb;
25(2):e198-e202.
PMID: 32043779
For pediatric patients with high-grade gliomas, standard-of-care treatment includes surgery, chemotherapy, and radiation therapy; however, most patients ultimately succumb to their disease. With advances in genomic characterization of pediatric high-grade...
9.
Ahmed A, Schriever C, Britt N, Yager J, Amin R, McGuey L, et al.
Ann Hepatol
. 2019 May;
18(4):601-606.
PMID: 31078440
Introduction And Objectives: Four regimens are recommended for treating hepatitis C (HCV) genotype 1 infection. Study aims were to (1) compare frequencies of contraindicated drug interactions (XDDIs) when each HCV...
10.
Severson E, Vergilio J, Gay L, Daniel S, Hemmerich A, Elvin J, et al.
Oncologist
. 2018 Sep;
24(3):372-374.
PMID: 30181314
BCR-ABL1-like B-Acute Lymphoblastic Leukemia (B-ALL) is a subset of B-ALL with a poor prognosis that is found in all age groups. Definitive identification of these patients is difficult in routine...